304 completed, 24 terminated, 23 unknown, 15 withdrawn. 115 Phase 4, 111 Phase 3, 62 Phase 2, 46 Phase 1, 30 Not applicable.
Follow Fluticasone: new trials by email Literature Review of Fluticasone trials Research Report on Fluticasone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR) Fluticasone 250mcg/Formoterol 12mcg/Glycopyrronium 25mcg, Comparator - Trimbow® - Chronic Obstructive Pulmonary Disease | Phase 3 | Not yet recruiting | Eurofarma Laboratorios S.A. | 1252 | 2027-01-30 | 2026-10-26 |
| Novel Method for Removal of Orally Deposited Inhaled Fluticasone Propionate Fluticasone Propionate, Water Mouthwash, EVOOW Mouthwash - Asthma | Phase 4 | Not yet recruiting | University of Wisconsin, Madison | 20 | 2026-11-01 | 2026-11-05 |
| Safety and Tolerability of Fluticasone Propionate 10% Nasal Insert in Participants With Chronic Allergic Rhinitis Fluticasone Propionate (FP) 10% Nasal Insert - Chronic Allergic Rhinitis | Phase 1 | Not yet recruiting | Dianosic | 25 | 2026-11-01 | 2026-11-05 |
| A Study to Visualize Multi-Symptom Allergy in Adults With Seasonal Allergic Rhinitis Fluticasone propionate - Rhinitis Allergic, Rhinitis Seasonal | Phase 4 | Not yet recruiting | HALEON | 16 | 2026-09-01 | 2026-09-14 |
| A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma. QVM149, Salmeterol Xinafoate / Fluticasone Propionate, Placebo to QVM149 - Asthma | Phase 3 | Recruiting | Novartis Pharmaceuticals | 188 | 2026-08-04 | 2026-10-15 |
| Non-Inferiority,Combination Formoterol/FluticasonexAlenia®Formoterol/Budesonide for Asthma in Brazil Administration of investigation drug, Administration of comparator - Moderate Asthma | Phase 3 | Withdrawn | Eurofarma Laboratorios S.A. | 2026-06-01 | 2025-12-18 | |
| Dymista in Chinese Adolescents Treatment with 137 µg azelastine hydrochloride and 50 μg of fluticasone propionate - Allergic Rhinitis Due to Allergens | Phase 4 | Completed | Viatris Inc. | 100 | 2026-05-08 | 2026-11-03 |
| Evaluation of the Adjunctive Effects of Moxibustion in the Treatment of Cold-Syndrome Allergic Rhinitis Mild moxibustion, Fluticasone propionate 100 mcg - Allergic Rhinitis (AR) | Not applicable | Active not recruiting | University of Medicine and Pharmacy at Ho Chi Minh City | 60 | 2026-03-01 | 2026-07-10 |
| Efficacy of Oral Nigella Sativa as Adjuvant Therapy in Children With Moderate Persistent Asthma Nigella sativa Oil Capsules (100 mg/kg/day), Nigella sativa Oil Capsules (50 mg/kg/day), Fluticasone / Long-Acting Beta-2 Agonist Combination - Community Acquired Pneumonia | Not applicable | Not yet recruiting | Tanta University | 90 | 2026-01-01 | 2026-01-02 |
| Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE Dupilumab, Fluticasone - Eosinophilic Esophagitis | Phase 2 | Recruiting | University of Colorado, Denver | 72 | 2024-12-23 | 2025-03-14 |
| A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma Fp/ABS, FP, ABS - Asthma | Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D LLC | 649 | 2024-12-12 | 2026-11-04 |
| Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma dupilumab, Matching Placebo, ICS/LABA - Asthma | Phase 4 | Active not recruiting | Regeneron Pharmaceuticals | 120 | 2024-08-26 | 2026-05-22 |
| BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP) Belumosudil, Fluticasone, Azithromycin - Bronchiolitis Obliterans Syndrome, Bronchiolitis Obliterans | Phase 2 | Recruiting | Dana-Farber Cancer Institute | 45 | 2024-05-31 | 2026-06-10 |
| Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old TEV-56248, Fp MDPI - Asthma | Phase 1 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 30 | 2024-05-16 | 2026-08-04 |
| Crisaborole vs Fluticasone Propionate in Mild to Moderate Atopic Dermatitis Crisaborole 2% topical ointment, Fluticasone propionate 0.05% topical cream - Atopic Dermatitis, Eczema | Not applicable | Completed | Noura Abdelmoneim Mohammed Elseessy | 40 | 2024-02-01 | 2026-04-17 |
| Advair HFA in Healthy and HAPE Predisposed Subjects Advair HFA, Placebo - Altitude Edema | Phase 1 / Phase 2 | Recruiting | University of Colorado, Denver | 60 | 2023-12-12 | 2025-09-22 |
| Bioequivalence Study for Fluticasone Propionate 500 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals, ADVAIR DISKUS® 500/50 - Bioequivalence | Phase 1 | Unknown | Respirent Pharmaceuticals Co Ltd. | 34 | 2023-08-22 | 2023-09-06 |
| Bioequivalence Study for Fluticasone Propionate 250 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals, ADVAIR DISKUS® 250/50 - Bioequivalence | Phase 1 | Unknown | Respirent Pharmaceuticals Co Ltd. | 34 | 2023-08-01 | 2023-08-31 |
| Bioequivalence Study for Fluticasone Propionate 100 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers Fluticasone propionate 1000 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals, ADVAIR DISKUS 100/50 - Bioequivalence | Phase 1 | Unknown | Respirent Pharmaceuticals Co Ltd. | 34 | 2023-02-17 | 2023-03-09 |
| Bioequivalence With Clinical Endpoint Study of Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals, ADVAIR DISKUS® 100/50 mcg inhalation powder pre-dispensed/GSK, Placebo - Asthma | Phase 3 | Unknown | Respirent Pharmaceuticals Co Ltd. | 451 | 2023-01-30 | 2023-03-01 |
Showing 20 of 385. Sign in to see all of them.
Asthma (164) · Pulmonary Disease, Chronic Obstructive (70) · Rhinitis, Allergic (30) · Rhinitis, Allergic, Seasonal (22) · Eosinophilic Esophagitis (17) · Rhinitis, Allergic, Perennial (11) · Hypersensitivity (10) · Bronchiolitis Obliterans Syndrome (5) · Emphysema (5) · Inflammation (5) · Nasal Polyps (5) · Rhinitis (5) · Bronchitis, Chronic (4) · COVID-19 (4) · Dermatitis, Atopic (4)
GlaxoSmithKline (88) · Respirent Pharmaceuticals Co Ltd. (20) · Teva Branded Pharmaceutical Products R&D, Inc. (11) · Boehringer Ingelheim (10) · Organon and Co (10) · Mundipharma Research Limited (9) · Novartis Pharmaceuticals (8) · SkyePharma AG (8) · University of Chicago (8) · AstraZeneca (7) · Dey (6) · Milton S. Hershey Medical Center (6) · Optinose US Inc. (6) · University of Dundee (6) · Meda Pharmaceuticals (5)
United States (176) · Germany (46) · United Kingdom (41) · Canada (35) · Poland (31) · Greece (25) · Netherlands (22) · Ukraine (22) · Russia (21) · Romania (20) · Spain (20) · Australia (18) · Hungary (18) · South Africa (18) · Belgium (16)
Ioannis Stefanidis, Professor (9) · Chrysoula Doxani, MD, MSc, PhD (6) · Robert M Naclerio, MD (4) · Adam Wanner, MD (3) · Elliot Israel, MD (3) · Lewis M Fredane, MD (3) · William Busse, MD (3) · Adrian Hernandez, MD (2) · Alison Chisholm, MSc (2)
PMID 36472162, PMID 24998880, PMID 27216137, PMID 20167147, PMID 23613569, PMID 23706709, PMID 25685162, PMID 27881132, PMID 34753535, PMID 35437059, PMID 37347518, PMID 11558866, PMID 15922813, PMID 16846553, PMID 17507702, PMID 17610727, PMID 17845589, PMID 18039368, PMID 18162137, PMID 18310480, PMID 18331513, PMID 19804441, PMID 19820080, PMID 19841453, PMID 19897551, PMID 19910033, PMID 20001651, PMID 20170333, PMID 20197425, PMID 20298399, PMID 20299628, PMID 20429821, PMID 20568384, PMID 20595155, PMID 20674827, PMID 20674829, PMID 20692026, PMID 20705799, PMID 20813884, PMID 20851928, PMID 20874458, PMID 20920764, PMID 21205715, PMID 21211642, PMID 21211643, PMID 21377716, PMID 21518040, PMID 21605396, PMID 21627828, PMID 21636667
2015 (4), 2016 (4), 2017 (3), 2014 (2), U10HL098115 (2), U24TR001608 (2), 2005 (1), 2008 (1), 2009 (1), 2023 (1), P50HL056385 (1), R01DK101856 (1), R01DK135692 (1), R01HL114899 (1), U01OH010404 (1)